Torrent Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of Cessation of Director of the Company'.
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has informed the stock exchanges that Dr. Maurice Chagnaud (DIN: 09592878) ceased to be a Director of the company effective 10th May 2025, after completing his tenure as an Independent Director. The filing is made under SEBI Listing Regulations, and the reason for cessation is stated as the natural completion of his term, not a resignation or removal. This follows an earlier communication from the company dated 24th January 2025, indicating the event was planned and anticipated.
This is a routine, pre-scheduled end of tenure for an Independent Director and is unlikely to have any material impact on the company's operations, strategy, or stock price. Shareholders should note that the board will need to fill this Independent Director position in due course as per SEBI norms.